« Highlights of the 5-year results of ContinuationPV study presented at ASH20 showing long-term hematological and deep molecular responses with ropeginterferon including eradication of JAK mutation in selected patients »
Long term use of ropeginterferon alpha in Polycy... - MPN Voice
Long term use of ropeginterferon alpha in Polycythemia Vera
Written by
Manouche
To view profiles and participate in discussions please or .
1 Reply
•
Now if the FDA would just get on the ball, I could switch from Pegasys.
Not what you're looking for?
You may also like...
Effective Management of Polycythemia Vera With Ropeginterferon Alfa-2b Treatment
Discussion;
The results in our study demonstrate that the new dosing regimen of 250-350-500 µg of...
Cost–effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera
What were the results?
Over a lifetime, the model showed that patients who received...
Bomedemstat in Patients With Polycythemia Vera
This is a Phase 2 open label study of an orally administered LSD1 inhibitor, bomedemstat...
Haemoglobin level in polycythemia vera
Does anyone know what a normal haemoglobin level is? My hb count on my last hospital letter was...
diagnosed with Polycythemia Vera
Hi everyone
It was confirmed yesterday that I have been diagnosed with Polycythemia Vera .
They...
New Study: Predicted Survival in Polycythemia Vera Patients
polycythemia vera ???
